Last reviewed · How we verify
ACE527
At a glance
| Generic name | ACE527 |
|---|---|
| Sponsor | TD Vaccines A/S |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults (PHASE1, PHASE2)
- Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea (PHASE2)
- ACE527 Safety and Immunogenicity Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |